We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
+18.43%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$289M
AUM Growth
+$27.3M
Cap. Flow
+$4.73M
Cap. Flow %
1.64%
Top 10 Hldgs %
61.4%
Holding
42
New
4
Increased
2
Reduced
14
Closed
5

Top Buys

Rank Stock Value
1
MORF
Morphic Holding, Inc. Common Stock
MORF
+$15M
2
CLVT icon
Clarivate
CLVT
+$10.6M
3
BHC icon
Bausch Health
BHC
+$8.59M
4
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$8.13M
5
SLDB icon
Solid Biosciences
SLDB
+$2.66M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$17.6M
2
APLS
Apellis Pharmaceuticals
APLS
+$3.62M
3
ARVN icon
Arvinas
ARVN
+$2.08M
4
TVTX icon
Travere Therapeutics
TVTX
+$2.06M
5
RLAY icon
Relay Therapeutics
RLAY
+$1.8M

Sector Composition

Rank Sector Weight
1 Healthcare 95.42%
2 Technology 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVIIW
26
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$76.7K 0.03%
548,000
– –
ROSS.WS
27
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$74.4K 0.03%
439,666
– –
CDAQW
28
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$68.4K 0.02%
459,906
– –
IVCPW
29
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$48K 0.02%
490,000
– –
GATEW
30
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$41.3K 0.01%
735,000
– –
AFTR.WS
31
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
$31.8K 0.01%
366,666
– –
CPAAW
32
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$28.6K 0.01%
571,666
– –
LSBPW
33
DELISTED
LakeShore Biopharma Warrants
LSBPW
$23K 0.01%
489,999
– –
CNDA.WS
34
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$16.3K 0.01%
408,333
– –
HPLTW
35
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$14.7K 0.01%
690,000
– –
TWCBW
36
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$9.33K ﹤0.01%
183,749
– –
ISEE
37
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-723,600
Closed -$17.6M
CORS.WS
38
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$0 ﹤0.01%
334,666
– –
HCNEW
39
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
– –
-387,249
Closed -$60.1K
ZTAQW
40
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
– –
-358,270
Closed -$60.1K
SNRHW
41
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
– –
-1,014,000
Closed -$51.3K
SKYAW
42
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
– –
-361,756
Closed -$18.1K
1
2

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return

Finepoint Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Finepoint Capital held 42 positions worth $289M, up 10% from $262M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Finepoint Capital's Q2 2023 filing shows 4 new, 2 increased, 14 reduced and 5 closed positions. Its largest new stake was Morphic Holding, Inc. Common Stock: 287,556 shares worth $16.5M. The largest sale was IVERIC bio, Inc. Common Stock, an estimated $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 99% a quarter earlier, followed by Technology.

  • Finepoint Capital's largest Q2 2023 buy was Morphic Holding, Inc. Common Stock: 287,556 shares worth $16.5M.
  • Finepoint Capital added most to Solid Biosciences in Q2 2023, an estimated $2.66M increase.
  • Finepoint Capital's biggest Q2 2023 reduction was Apellis Pharmaceuticals, cutting an estimated $3.62M.
  • Finepoint Capital fully exited IVERIC bio, Inc. Common Stock in Q2 2023, selling an estimated $17.6M.
  • Finepoint Capital's ten largest holdings make up 61% of its $289M portfolio in Q2 2023.
  • Finepoint Capital opened 4 new positions and closed 5 in Q2 2023.
  • Finepoint Capital's portfolio value rose 10% quarter-over-quarter to $289M.

Based on Finepoint Capital's 13F filing for Q2 2023, filed 11 Aug 2023.